logo

Aurinia Pharmaceuticals Inc. (AUPH)



Trade AUPH now with
  Date
  Headline
7/27/2020 10:34:12 AM Aurinia Closes $200 Mln Public Offering Of Common Shares
7/22/2020 11:11:24 PM Aurinia Pharma Announces Pricing Of Underwritten Public offering Of 13.33 Mln Shares At US$15.00/shr
6/22/2020 6:09:21 AM Aurinia Completes Patient Enrollment Into AUDREY Phase 2/3 Clinical Trial Of Voclosporin Ophthalmic Solution
6/9/2020 6:10:21 AM Aurinia Pharma Presents Addl AURORA Pivotal Trial Safety Data At ERA-EDTA Virtual Congress 2020
6/5/2020 7:11:24 AM AbbVie, Harbour BioMed, Utrecht University And Erasmus Medical Center Announcee Collaboation
6/5/2020 7:09:05 AM Aurinia Presents New Subgroup Analyses From Completed AURORA Pivotal Trial Of Voclosporin
6/3/2020 6:08:48 AM Aurinia Pharma Says Nine Incumbent Directors Elected At Annual General Meeting
5/26/2020 6:08:41 AM Aurinia Completes Submission Of NDA To FDA For Voclosporin For Treatment Of Lupus Nephritis
5/14/2020 4:04:02 PM Aurinia Q1 Loss/share $0.15 Vs. Loss $0.14 Year Ago
4/27/2020 6:08:38 AM Aurinia Appoints Joe Miller As CFO
4/20/2020 6:11:31 AM Aurinia Appoints Timothy Walbert To Board
3/18/2020 6:07:08 AM Aurinia Announces AURORA Phase 3 Clinical Data For Voclosporin To Be Presented At NKF 2020 Spring Clinical Meetings
3/17/2020 6:02:48 AM Aurinia Pharma Establishes U.S. Commercial Operations Center In Rockville, Maryland
3/16/2020 6:21:11 AM Aurinia Initiates Rolling Submission Of NDA To FDA For Voclosporin
3/12/2020 7:08:24 AM Aurinia Pharma Announces New Initiatives To Support Lupus Nephritis Community And Raise Disease Awareness
12/12/2019 9:29:04 AM Aurinia Closes Public Offering Of 12.78 Mln Common Shares